Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies. But current cancer assessment methods have limited specificity and sensitivity and can be prohibitively expensive. In a study led by investigators from Mass General Brigham , the Wyss Institute for Biologically Inspired Engineering at Harvard University and Dana-Farber Cancer Institute , in collaboration with researchers from across the country and beyond the U.

https://www.miragenews.com/pan-cancer-biomarker-detected-by-ultrasensitive-1098421/

#miragenews